Leslie Madden is an experienced senior director in regulatory science and quality assurance, currently leading efforts in Canada at Moderna since May 2021. Previously, Leslie held roles at Elvium as Director of Regulatory Affairs and at Biogen, where responsibilities included Global Regulatory Lead for the Multiple Sclerosis Franchise and leadership in commercial strategy for SPINRAZA. Early career experiences include positions at Galderma and GlaxoSmithKline, focusing on regulatory affairs. Leslie holds a Global Professional Masters of Law (LLM) from the University of Toronto Faculty of Law, an MBA from the Rotman School of Management at the University of Toronto, a Bachelor of Science in Biology from York University, and a Post-Graduate Certificate in Regulatory Affairs and Quality Control from Seneca Polytechnic.
March, 2022 - present
May, 2021